Elevated tissue inhibitor of metalloproteinase-1 along with left atrium hypertrophy predict atrial fibrillation recurrence after catheter ablation

Elevated tissue inhibitor of metalloproteinase-1 along with left atrium hypertrophy predict atrial fibrillation recurrence after catheter ablation

This study aimed to establish a model that predicts atrial fibrillation (AF) recurrence after catheter ablation using clinical risk factors and biomarkers. We used a prospective cohort study, including 230 consecutive persistent AF patients successfully treated with catheter ablation from January 20...

Full description

Bibliographic Details
Main Authors: Weiping Sun, Haiwei Li, Zefeng Wang, Qin Li, Haichu Wen, Yongquan Wu, Jie Du
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
atrial fibrillation
biomarkers
TIMP metallopeptidase inhibitor 1
recurrence
left atrium diameter
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1010443/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.1010443/full

Similar Items